Is SILK or JNJ a better dividend investment in 2026?

SILK currently yields 7.28% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: SILK offers higher current income.

What is the dividend yield difference between SILK and JNJ?

SILK has a forward dividend yield of 7.28% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 3.92 percentage points.

Home › Compare › SILK vs JNJ

SILK vs JNJ: Dividend Comparison 2026

SILK yields 7.28% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SILK wins by $12.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SILK

● Live price

7.28%

Share price

$27.49

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$32.4K

Annual income

$1,154.32

Full SILK calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — SILK vs JNJ

📍 SILK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SILK	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SILK + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SILK pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SILK

Annual income on $10K today (after 15% tax)

$618.41/yr

After 10yr DRIP, annual income (after tax)

$981.17/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, SILK beats the other by $277.56/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SILK + JNJ for your $10,000?

SILK: 50%JNJ: 50%

100% JNJ50/50100% SILK

Portfolio after 10yr

$26.2K

Annual income

$991.05/yr

Blended yield

3.78%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SILK

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$30.58

+11.2% upside vs current

Range: $20.00 — $46.00

Altman Z

4.6

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SILK buys

JNJ buys

No recent congressional trades found for SILK or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSILKJNJ

Forward yield	7.28% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$32.4K ✓	$20.0K
Annual income after 10y	$1,154.32 ✓	$827.78
Total dividends collected	$9.5K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy
Analyst price target	$30.58	$228.73 ✓

Year-by-year: SILK vs JNJ ($10,000, DRIP)

Year	SILK Portfolio	SILK Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,428	$727.54	$10,676	$355.77	+$752.00 → SILK
2	$13,004	$777.01	$11,407	$389.39	+$1.6K → SILK
3	$14,741	$826.38	$12,198	$426.53	+$2.5K → SILK
4	$16,649	$875.46	$13,056	$467.62	+$3.6K → SILK
5	$18,738	$924.05	$13,987	$513.12	+$4.8K → SILK
6	$21,022	$971.98	$14,998	$563.56	+$6.0K → SILK
7	$23,512	$1,019.10	$16,098	$619.52	+$7.4K → SILK
8	$26,223	$1,065.28	$17,295	$681.69	+$8.9K → SILK
9	$29,169	$1,110.38	$18,599	$750.82	+$10.6K → SILK
10	$32,366	$1,154.32	$20,022	$827.78	+$12.3K → SILK

SILK vs JNJ: Complete Analysis 2026

SILK — Stock

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Full SILK Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this SILK vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SILK vs SCHD SILK vs JEPI SILK vs O SILK vs KO SILK vs MAIN SILK vs ABBV SILK vs MRK SILK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.